{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:36:25Z","timestamp":1777660585726,"version":"3.51.4"},"reference-count":138,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Genetic Testing and Molecular Biomarkers"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) displays a broad spectrum of clinical presentations ranging from lack of symptoms to severe multiorgan system complications and death. Various laboratory assays have been employed in the diagnosis of COVID-19, including: nucleic acid-based tests; antigen tests; and serum testing for anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies. The disease can also be diagnosed based on suggestive clinical features and radiological findings. Until now, remdesivir is the only medication approved for the treatment of COVID-19 by the U.S. Food and Drug Administration (FDA); however, it is anticipated that several anti-SARS-CoV-2 monoclonal antibodies will gain soon approval. Other methods of treatment include supportive care directed toward treating the symptoms. Nevertheless, many studies have recently emerged, showing controversial preliminary results with the off-label medication hydroxychloroquine. Given that all results are still preliminary, including those seen by remdesivir, additional evidence and research are required to identify effective medications that are broadly effective and well tolerated. Importantly, two RNA-based vaccines have recently gained approval from Pfizer and Moderna, with many others still in clinical trials. This article reviews various aspects of COVID-19, including its epidemiology; its evolution and mutational spectrum; and its clinical dynamics, symptoms and complications, diagnosis, and treatment.<\/jats:p>","DOI":"10.1089\/gtmb.2020.0227","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:40:45Z","timestamp":1613580045000},"page":"85-101","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment"],"prefix":"10.1177","volume":"25","author":[{"given":"Nour K.","family":"Younis","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana O.","family":"Zareef","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali N.","family":"Maktabi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Mahfouz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00646-x"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00610-8"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200642"},{"key":"e_1_3_4_5_1","article-title":"CoV Genome Tracker: tracing genomic footprints of Covid-19 pandemic","author":"Akther S","year":"2020","unstructured":"Akther S, , Bezrucenkovas E, , Sulkow B, et al. (2020) CoV Genome Tracker: tracing genomic footprints of Covid-19 pandemic. bioRxiv [Epub ahead of print]; DOI: 10.1101\/2020.04.10.036343.","journal-title":"bioRxiv"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25719"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.020"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009020"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200463"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10090669"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2020.1739001"},{"key":"e_1_3_4_13_1","first-page":"FL","article-title":"Features, Evaluation and Treatment Coronavirus (COVID-19)","author":"Cascella M","year":"2020","unstructured":"Cascella M, , Rajnik M, , Cuomo A, et al. (2020) Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls, Treasure Island, FL.","journal-title":"StatPearls, Treasure Island,"},{"key":"e_1_3_4_14_1","unstructured":"Centers for Disease Control and Prevention (2020a) Coronavirus disease 2019 (COVID-19). Available at https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/index.html accessed August1 2020."},{"key":"e_1_3_4_15_1","unstructured":"Centers for Disease Control and Prevention (2020b) Interim guidelines for COVID-19 antibody testing. Available at https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/resources\/antibody-testsguidelines.html accessed August1 2020."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25700"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1719902"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30141-9"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25681"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.03.005"},{"key":"e_1_3_4_21_1","unstructured":"China National Center for Bioinformation (2020) 2019 Novel coronavirus resource (2019nCoVR). Available at https:\/\/bigd.big.ac.cn\/ncov\/?lang=en accessed August1 2020."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200230"},{"key":"e_1_3_4_23_1","first-page":"1","article-title":"COVID-19 outbreak: an overview","volume":"64","author":"Ciotti M","year":"2020","unstructured":"Ciotti M, , Angeletti S, , Minieri M, et al. (2020) COVID-19 outbreak: an overview. Chemotherapy, 64:1-9.","journal-title":"Chemotherapy"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.03.005"},{"key":"e_1_3_4_26_1","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta D","year":"2020","unstructured":"Cucinotta D, , Vanelli M (2020) WHO declares COVID-19 a pandemic. Acta Biomed, 91:157-160.","journal-title":"Acta Biomed"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.02.011"},{"key":"e_1_3_4_28_1","article-title":"Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein","author":"Diao B WK","year":"2020","unstructured":"Diao B WK, , Chen J, , Liu Y, et al. (2020) Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein. MedRxiv [Epub ahead of print]; DOI: 10.1101\/2020.03.07.20032524.","journal-title":"MedRxiv"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25820"},{"key":"e_1_3_4_30_1","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [in Chinese]","volume":"41","author":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention","year":"2020","unstructured":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention (2020) The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi, 41:145-151.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16474"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004999117"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01047"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007016"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa310"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25749"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25766"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_3_4_41_1","article-title":"Evidence of the recombinant origin and ongoing mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Huang J-M","year":"2020","unstructured":"Huang J-M, , Jan SS, , Wei X, et al. (2020b) Evidence of the recombinant origin and ongoing mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). bioRxiv [Epub ahead of print]; DOI: 10.1101\/2020.03.16.993816.","journal-title":"bioRxiv"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1096"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00266-20"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30068-1"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.036"},{"key":"e_1_3_4_46_1","article-title":"Phylogenetic analysis of the novel coronavirus reveals important variants in Indian strains","author":"Joshi A","year":"2020","unstructured":"Joshi A, , Paul S (2020) Phylogenetic analysis of the novel coronavirus reveals important variants in Indian strains. bioRxiv [Epub ahead of print]; DOI: 10.1101\/2020.04.14.041301.","journal-title":"bioRxiv"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4742"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.20.253591"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2783"},{"key":"e_1_3_4_51_1","first-page":"1","article-title":"SARS-CoV-2 vaccine candidates in rapid development","volume":"16","author":"Li L","year":"2020","unstructured":"Li L, , Guo P, , Zhang X, et al. (2020a) SARS-CoV-2 vaccine candidates in rapid development. Hum Vaccin Immunother, 16:1-10.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25727"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0198"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047549"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa021"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30232-2"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1745095"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25678"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m641"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4362"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1036"},{"key":"e_1_3_4_63_1","article-title":"Comparative analysis based on the spike glycoproteins of SARS-CoV2 isolated from COVID 19 patients of different countries","author":"Mangar P","year":"2020","unstructured":"Mangar P, , Pradhan S, , Rai S, et al. (2020) Comparative analysis based on the spike glycoproteins of SARS-CoV2 isolated from COVID 19 patients of different countries. PrePrints; DOI: 10.20944\/preprints202004.0154.v1.","journal-title":"PrePrints"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31324-6"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30530-0"},{"key":"e_1_3_4_67_1","first-page":"1775","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder G","year":"2020","unstructured":"Onder G, , Rezza G, , Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA, 323:1775-1776.","journal-title":"JAMA"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200370"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06731-x"},{"key":"e_1_3_4_70_1","article-title":"Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study","author":"Pasomsub E","year":"2020","unstructured":"Pasomsub E, , Watcharananan SP, , Boonyawat K, et al. (2020) Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin Microbiol Infect [Epub ahead of print]; DOI: 10.1016\/j.cmi.2020.05.001.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00722-20"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104260"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.05.098"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16387"},{"key":"e_1_3_4_75_1","article-title":"Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report","author":"Recovery Collaborative Group","year":"2020","unstructured":"Recovery Collaborative Group; Horby P, , Lim WS, et al. (2020) Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N Engl J Med [Epub ahead of print]; DOI: 10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.3934\/mbe.2020149"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102433"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05991-x"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa006"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00806-5"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4783"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa203"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-019-0181-7"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"e_1_3_4_85_1","unstructured":"Shu C Huang X Brosius J Deng C (2020) Exploring potential super infection in SARS-CoV2 by genome-wide analysis and receptor-ligand docking. PrePrints; 2020030310."},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02501-05"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30453-7"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30172-7"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00512-20"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25829"},{"key":"e_1_3_4_91_1","unstructured":"Times (2020). WHO resumes study of hydroxychloroquine for treating COVID-19. Available at https:\/\/time.com\/5847664\/who-hydroxychloroquine-covid-19\/ accessed August2 2020."},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa149"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30196-1"},{"key":"e_1_3_4_94_1","unstructured":"U.S. Food and Drug Administration (FDA) (2020a) Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19. FDA. Available at https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19 accessed December9 2020."},{"key":"e_1_3_4_95_1","unstructured":"U.S. Food and Drug Administration (FDA) (2020b) Coronavirus (COVID-19) update: FDA issues emergency use authorization for potential COVID-19 treatment."},{"key":"e_1_3_4_96_1","unstructured":"U.S. Food and Drug Administration (FDA) (2020c) Emergency use authorizations."},{"key":"e_1_3_4_97_1","unstructured":"U.S. Food and Drug Administration (FDA) (2020d) FDA's approval of Veklury (remdesivir) for the treatment of COVID-19\u2014The Science of Safety and Effectiveness."},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28692"},{"key":"e_1_3_4_99_1","article-title":"Positive selection of ORF3a and ORF8 genes drives the evolution of SARS-CoV-2 during the 2020 COVID-19 pandemic","author":"Velazquez-Salinas L","year":"2020","unstructured":"Velazquez-Salinas L, , Zarate S, , Eberl S, et al. (2020) Positive selection of ORF3a and ORF8 genes drives the evolution of SARS-CoV-2 during the 2020 COVID-19 pandemic. bioRxiv [Epub ahead of print]; DOI: 10.1101\/2020.04.10.035964.","journal-title":"bioRxiv"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25762"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_3_4_102_1","article-title":"SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution","author":"Wang H","year":"2020","unstructured":"Wang H, , Hou X, , Wu X, et al. (2020c) SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution. bioRxiv [Epub ahead of print]; DOI: 10.1101\/2020.03.26.994756.","journal-title":"bioRxiv"},{"key":"e_1_3_4_103_1","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang W","year":"2020","unstructured":"Wang W, , Xu Y, , Gao R, et al. (2020d) Detection of SARS-CoV-2 in different types of clinical specimens. JAMA, 323:1843-1844.","journal-title":"JAMA"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1808"},{"key":"e_1_3_4_105_1","volume-title":"Advice on the use of point-of-care immunodiagnostic tests for COVID-19","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020a) Advice on the use of point-of-care immunodiagnostic tests for COVID-19. Geneva: World Health Organization."},{"key":"e_1_3_4_106_1","volume-title":"Clinical management of severe acute respiratory infection when COVID-19 is suspected","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020b) Clinical management of severe acute respiratory infection when COVID-19 is suspected. Geneva: World Health Organization."},{"key":"e_1_3_4_107_1","volume-title":"Coronavirus disease (COVID-19): dexamethasone","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020c) Coronavirus disease (COVID-19): dexamethasone. Geneva: World Health Organization."},{"key":"e_1_3_4_108_1","volume-title":"COVID-19 weekly epidemiological update","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020d) COVID-19 weekly epidemiological update. Geneva: World Health Organization."},{"key":"e_1_3_4_109_1","volume-title":"Draft landscape of COVID-19 candidate vaccines","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020e). Draft landscape of COVID-19 candidate vaccines. Geneva: World Health Organization."},{"key":"e_1_3_4_110_1","volume-title":"Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020f) Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. Geneva: World Health Organization."},{"key":"e_1_3_4_111_1","volume-title":"Naming the coronavirus disease (COVID-19) and the virus that causes it","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020g) Naming the coronavirus disease (COVID-19) and the virus that causes it. Geneva: World Health Organization."},{"key":"e_1_3_4_112_1","volume-title":"Novel coronavirus (2019-nCoV): situation report 3, January 23, 2020","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020h) Novel coronavirus (2019-nCoV): situation report 3, January 23, 2020. Geneva: World Health Organization."},{"key":"e_1_3_4_113_1","volume-title":"Novel coronavirus (2019-nCoV): situation report\u201410, January 30, 2020","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020i) Novel coronavirus (2019-nCoV): situation report\u201410, January 30, 2020. Geneva: World Health Organization."},{"key":"e_1_3_4_114_1","volume-title":"Q&A: hydroxychloroquine and COVID-19","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020j) Q&A: hydroxychloroquine and COVID-19. Geneva: World Health Organization."},{"key":"e_1_3_4_115_1","volume-title":"WHO Director-General's opening remarks at the media briefing on COVID-19\u2014March 11, 2020","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO) (2020k) WHO Director-General's opening remarks at the media briefing on COVID-19\u2014March 11, 2020. Geneva: World Health Organization."},{"key":"e_1_3_4_116_1","volume-title":"Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020","author":"World Health Organization (WHO)","unstructured":"World Health Organization (WHO) (202l) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. Geneva: World Health Organization."},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"e_1_3_4_118_1","article-title":"Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs","author":"Wyllie AL","year":"2020","unstructured":"Wyllie AL, , Fournier J, , Casanovas-Massana A, et al. (2020) Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. MedRxiv [Epub ahead of print]; DOI: 10.1101\/2020.04.16.20067835.","journal-title":"MedRxiv"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200343"},{"key":"e_1_3_4_120_1","article-title":"Comparative performance of four nucleic acid amplification tests for SARS-CoV-2 virus","author":"Xiong Y","year":"2020","unstructured":"Xiong Y, , Li Z-Z, , Zhuang Q-Z, et al. (2020) Comparative performance of four nucleic acid amplification tests for SARS-CoV-2 virus. bioRxiv [Epub ahead of print]; DOI: 10.1101\/2020.03.26.010975.","journal-title":"bioRxiv"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.02.016"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"e_1_3_4_124_1","article-title":"Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections","author":"Yang Y","year":"2020","unstructured":"Yang Y, , Yang M, , Shen C, et al. (2020d) Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. MedRxiv [Epub ahead of print]; DOI: 10.1101\/2020.02.11.20021493.","journal-title":"MedRxiv"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12034"},{"key":"e_1_3_4_126_1","article-title":"Evaluation of the auxiliary diagnosis value of antibodies assays for the detection of novel coronavirus (SARS-Cov-2)","author":"Yong G","year":"2020","unstructured":"Yong G, , Yi Y, , Tuantuan L, et al. (2020) Evaluation of the auxiliary diagnosis value of antibodies assays for the detection of novel coronavirus (SARS-Cov-2). medRxiv [Epub ahead of print]; DOI: 10.1101\/2020.03.26.20042044.","journal-title":"medRxiv"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.597985"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.612460"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01424-5"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0360-5"},{"key":"e_1_3_4_131_1","article-title":"Identification of 22\u2009N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications on vaccination and antibody therapeutics","author":"Zhou D","year":"2020","unstructured":"Zhou D, , Qi R, , Zhang W, et al. (2020a) Identification of 22\u2009N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications on vaccination and antibody therapeutics. Preprints; DOI: 10.20944\/preprints202002.0381.v2.","journal-title":"Preprints"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0767-8"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.07.026"},{"key":"e_1_3_4_136_1","article-title":"Clinical reports on early diagnosis of novel coronavirus (2019-nCoV) pneumonia in stealth infected patients","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, , Yang L, , Han M, et al. (2020f) Clinical reports on early diagnosis of novel coronavirus (2019-nCoV) pneumonia in stealth infected patients. PrePrints; DOI: 10.20944\/preprints202002.0156.v1.","journal-title":"PrePrints"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_3_4_138_1","doi-asserted-by":"crossref","unstructured":"Zhu Z Liu G Meng K et al. (2020b) Rapid spread of mutant alleles in worldwide COVID-19 strains revealed by genome-wide SNP analysis [Epub ahead of print]; DOI: 10.21203\/rs.3.rs-23205\/v1.","DOI":"10.21203\/rs.3.rs-23205\/v1"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200490"}],"container-title":["Genetic Testing and Molecular Biomarkers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/gtmb.2020.0227","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/gtmb.2020.0227","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/gtmb.2020.0227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:54Z","timestamp":1777447374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/gtmb.2020.0227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1089\/gtmb.2020.0227"],"URL":"https:\/\/doi.org\/10.1089\/gtmb.2020.0227","relation":{},"ISSN":["1945-0265","1945-0257"],"issn-type":[{"value":"1945-0265","type":"print"},{"value":"1945-0257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}